Provided by Tiger Trade Technology Pte. Ltd.

Agios Pharmaceuticals

31.80
-0.6800-2.09%
Post-market: 31.800.00000.00%19:30 EDT
Volume:569.93K
Turnover:18.22M
Market Cap:1.89B
PE:-4.54
High:32.82
Open:32.82
Low:31.65
Close:32.48
52wk High:46.00
52wk Low:22.24
Shares:59.47M
Float Shares:50.09M
Volume Ratio:0.47
T/O Rate:1.14%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.0075
EPS(LYR):-7.1203
ROE:-34.34%
ROA:-22.24%
PB:1.84
PE(LYR):-4.47

Loading ...

BofA Securities Adjusts Agios Pharmaceuticals Price Target to $50 From $46, Maintains Buy Rating

MT Newswires Live
·
Sep 21

Agios Pharmaceuticals price target raised to $50 from $46 at BofA

TIPRANKS
·
Sep 21

Agios Pharmaceuticals (AGIO) Could Be 24% Undervalued On PYRUKYND Growth Hopes

Simply Wall St.
·
Aug 18

Analysts Conflicted on These Healthcare Names: GE Healthcare Technologies Inc (GEHC), Vertex Pharmaceuticals (VRTX) and Agios Pharma (AGIO)

TIPRANKS
·
Aug 11

Agios Pharmaceuticals (AGIO) In Focus On Earnings As Undervalued Narrative Holds

Simply Wall St.
·
Aug 09

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Agios Pharma (AGIO), Novavax (NVAX) and Keros Therapeutics (KROS)

TIPRANKS
·
Aug 04

U.S. Research Roundup-Abbvie, Amazon, Illumina

Reuters
·
Aug 03

Agios Pharmaceuticals Inc : Leerink Partners Raises Target Price to $73 from $62

THOMSON REUTERS
·
Aug 03

Agios Pharmaceuticals is Maintained at Buy by Truist Securities

Dow Jones
·
Jul 31

Agios Pharmaceuticals Inc : Truist Securities Cuts Target Price to $39 from $41

THOMSON REUTERS
·
Jul 31

U.S. Research ROUNDUP-Apple, Amazon, Mastercard

Reuters
·
Jul 31

Agios Pharmaceuticals price target raised to $55 from $52 at H.C. Wainwright

TIPRANKS
·
Jul 31

Agios Pharmaceuticals Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Jul 30

Agios Pharmaceuticals Q2 Loss Narrows as Revenue Increases

MT Newswires Live
·
Jul 30

Agios Q2 Revenue Jumps on US Commercial Launch of Aqvesme

Reuters
·
Jul 30

Earnings Flash (AGIO) Agios Pharmaceuticals Posts Q2 Net Loss $1.69 a Share, vs. FactSet Est of $1.71 Loss

MT Newswires Live
·
Jul 30

Agios Pharmaceuticals Q2 EPS $(1.69) Misses $(1.67) Estimate, Sales $44.745M Beat $25.521M Estimate

Benzinga Earnings
·
Jul 30

Agios Pharmaceuticals Q2 Product Revenue USD 44.745 Million Vs. IBES Estimate USD 25.5 Million

Reuters
·
Jul 30

U.S. Research ROUNDUP-Blackstone, Hartford Insurance, Zevra Therapeutics

Reuters
·
Jul 27

Agios Pharmaceuticals Inc : Leerink Partners Raises Target Price to $62 from $59

THOMSON REUTERS
·
Jul 27